TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Nordic Executive Medicine AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
3,919
|
4,952
|
4,810 |
| Financial expenses |
11
|
10
|
15 |
| Earnings before taxes |
-191
|
51
|
453 |
| EBITDA |
-180
|
61
|
469 |
| Total assets |
531
|
707
|
593 |
| Current assets |
506
|
682
|
568 |
| Current liabilities |
479
|
575
|
464 |
| Equity capital |
52
|
132
|
129 |
| - share capital |
50
|
50
|
50 |
| Employees (average) |
6
|
7
|
5 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
9.8%
|
18.7%
|
21.8% |
| Turnover per employee |
653
|
707
|
962 |
| Profit as a percentage of turnover |
-4.9%
|
1.0%
|
9.4% |
| Return on assets (ROA) |
-33.9%
|
8.6%
|
78.9% |
| Current ratio |
105.6%
|
118.6%
|
122.4% |
| Return on equity (ROE) |
-367.3%
|
38.6%
|
351.2% |
| Change turnover |
-1,033
|
142
|
1,779 |
| Change turnover % |
-21%
|
3%
|
59% |
| Chg. No. of employees |
-1
|
2
|
2 |
| Chg. No. of employees % |
-14%
|
40%
|
67% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.